NEW ORLEANS – Ochsner Health System has been named one of four finalists in the Health Acceleration Challenge by the Forum on Health Care Innovation – a collaboration between Harvard Business School (HBS) and Harvard Medical School (HMS) – for its work on the Ochsner Hypertension Digital Medicine Program. The challenge focuses on taking compelling, already-implemented health care solutions and helping them to grow and increase their impact through powerful networking and funding opportunities.
Last year, Ochsner created innovationOchsner (iO), an innovation lab and accelerator that designs patient-centered solutions through technology and data to empower patients to take an active role in their own health and improve efficiency for physicians and clinicians. iO used Apple Watch as a tool to enhance the effectiveness of the Ochsner Hypertension Digital Medicine Program, a program that monitors clinic patients who struggle with uncontrolled blood pressure. Utilizing wireless blood pressure cuffs integrated with AppleHealthKit and Epic, Ochsner’s Electronic Medical Record (EMR), patients regularly measure their blood pressure ratings at home while the data is sent directly to the clinic for monitoring. Specialized pharmacists review the data in real time to provide feedback about important aspects of their care. This could include potential side effects once a new medication is prescribed, renewal notification for prescriptions and medications, and lifestyle modification reminders to ensure good blood pressure control is attained. This new virtual delivery model works by delivering significantly better health outcomes, patient satisfaction and patient engagement
“The Hypertension Digital Medicine program focuses on better management of hypertension informed by home-based monitoring, enabling our providers to tailor individualized care plans as well as provide patient-specific reports,” said Richard Milani, M.D., Chief Clinical Transformation Officer, Ochsner Health System. “Collecting data from patients’ daily lives gives us a more comprehensive picture of patient health and information to guide prevention recommendations and chronic care management and engages patients as active members of the healthcare team.”
A team of 24 judges – a mix of clinicians, health care professionals and academics – specializing in health care and innovation, reviewed the applications. Applications were rated based on the three Challenge criteria of impact, evidence and dissemination, and given an overall score to create a short list of 21 innovations. These 21 innovations went through additional rounds of judging to identify 7 ‘shortlisted’ candidates and, ultimately, 4 strong finalists.
“It’s an honor to be named a finalist in the Health Acceleration Challenge,” said Aimee Quirk, CEO, innovationOchsner. “It highlights our focus on creating innovative solutions for the most pressing issues our patients face. We remain committed to creating new solutions enabled by technology to enhance quality of care, convenience and satisfaction for our patients and to scaling them to maximize impact.”
Ochsner received a monetary prize along with the other three finalists. A winner will be announced next year after the four finalists have pursued their dissemination plans. Each will become the subject of an HBS case study. Since its launch in 2014, the Health Acceleration Challenge has received over 600 applications and attracted more than 25,000 online visitors from 29 countries.
The funding for the Health Acceleration Challenge was provided by a generous gift from Howard E. Cox, Jr. (MBA 1969), a former general partner and now advisory partner in one of the country’s first and most successful venture capital firms, Greylock Partners, and a member of both the HBS Healthcare Initiative Advisory Board and the HMS Board of Fellows. During his long and distinguished career, Cox has been involved in the funding and development of many successful healthcare ventures.
The HBS-HMS Forum on Health Care Innovation is led by a steering committee composed of Sterling as well as MBA Class of 1961 Professor of Management Practice Richard G. Hamermesh and Albert J. Weatherhead III Professor of Business Administration Robert S. Huckman, all from Harvard Business School, and from Harvard Medical School, Dr. Barbara J. McNeil, Ridley Watts Professor and founding head of the Department of Health Care Policy, and Joseph P. Newhouse, John D. MacArthur Professor of Health Policy and Management.
To learn more or to follow the challenge, please visit www.healthaccelerationchallenge.com.
innovationOchsner (iO) is an innovation lab and accelerator whose mission is to reimagine and revolutionize the experience and delivery of healthcare by enhancing quality, affordability and access. iO designs solutions using technology and data to empower patients to take an active role in their own health and to improve efficiency for physicians and clinicians. iO was founded by Ochnser Health System, Louisiana's largest non-profit health system with 28 owned, managed and affiliated hospitals and more than 60 health centers. Ochsner is recognized by U.S. News & World Report as a "Best Hospital" across three specialty categories and cares for patients from all 50 states and more than 80 countries worldwide each year. Ochsner employs more than 17,000 employees and over 1,000 physicians in over 90 medical specialties and subspecialties, and conducts more than 1,000 clinical research studies. For more information, please visit innovationochsner.com or follow Ochsner Health System on Twitter and Facebook.
THE HBS-HMS Forum on Health Care Innovation
The Forum on Health Care Innovation is collaboration between Harvard Business School (HBS) and Harvard Medical School (HMS). Its purpose is to unite leading executives, policymakers, and academics in a cross-disciplinary exploration of innovative actions to improve quality, reduce costs, and, ultimately, increase value in the health care industry. In 2014 the Forum launched the Health Acceleration Challenge to identify and promote demonstrated health care innovations, and selected four finalists and one winner to share the Cox Prize.
Harvard Business School
Founded in 1908 as part of Harvard University, Harvard Business School is located on a 40-acre campus in Boston. Its faculty of more than 200 offers full-time programs leading to the MBA and doctoral degrees, as well as more than 80 open enrollment Executive Education programs and more than 60 custom programs. For more than a century, HBS faculty have drawn on their research, their experience in working with organizations worldwide, and their passion for teaching to educate leaders who have shaped the practice of business and entrepreneurship around the globe.
Harvard Medical School (http://hms.harvard.edu) has more than 7,500 full-time faculty working in 10 academic departments located at the School’s Boston campus or in hospital-based clinical departments at 15 Harvard-affiliated teaching hospitals and research institutes: Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Brigham and Women’s Hospital, Cambridge Health Alliance, Dana-Farber Cancer Institute, Harvard Pilgrim Health Care Institute, Hebrew SeniorLife, Joslin Diabetes Center, Judge Baker Children’s Center, Massachusetts Eye and Ear/Schepens Eye Research Institute, Massachusetts General Hospital, McLean Hospital, Mount Auburn Hospital, Spaulding Rehabilitation Hospital and VA Boston Healthcare System.